Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy. | Front Allergy | 2022 | 35991310 | PubTator, text mining | PubMed |
| From rare disorders of immunity to common determinants of infection: Following the mechanistic thread. | Cell | 2022 | 35985287 | PubTator, text mining | PubMed |
| Intestinal CD8+ tissue-resident memory T cells: From generation to function. | Eur J Immunol | 2022 | 35985020 | PubTator, text mining | PubMed |
| CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse. | Front Immunol | 2022 | 35983040 | PubTator, text mining | PubMed |
| Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy. | J Immunother Cancer | 2022 | 35981785 | PubTator, text mining | PubMed |
| MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase. | PLoS One | 2022 | 35980936 | PubTator, text mining | PubMed |
| Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies. | Front Immunol | 2022 | 35979372 | PubTator, text mining | PubMed |
| Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts. | J Hematol Oncol | 2022 | 35978433 | PubTator, text mining | PubMed |
| The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. | Front Immunol | 2022 | 35967413 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis | Balkan Med J | 2022 | 35965424 | PubTator, text mining | PubMed |
| Correlation of CT-derived pectoralis muscle status and COVID-19 induced lung injury in elderly patients. | BMC Med Imaging | 2022 | 35962312 | PubTator, text mining | PubMed |
| Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review. | Front Oncol | 2022 | 35957865 | PubTator, text mining | PubMed |
| Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies. | Cancers (Basel) | 2022 | 35954440 | PubTator, text mining | PubMed |
| Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma. | Cancers (Basel) | 2022 | 35954378 | PubTator, text mining | PubMed |
| The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia. | Clin Hematol Int | 2022 | 35950210 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Epigenetic regulation and T-cell responses in endometriosis - something other than autoimmunity. | Front Immunol | 2022 | 35935991 | PubTator, text mining | PubMed |
| Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. | J Immunol Res | 2022 | 35915657 | PubTator, text mining | PubMed |
| Evaluation of the clinical utility of the PromarkerD in-vitro test in predicting diabetic kidney disease and rapid renal decline through a conjoint analysis. | PLoS One | 2022 | 35913946 | PubTator, text mining | PubMed |
| Combination Approaches to Target PD-1 Signaling in Cancer. | Front Immunol | 2022 | 35911672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=29